scieee Open visual document viewer

Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells

Pascual Hernández, Álvaro; Ballesta Mudarra, Sofía; García Luque, Isabel; Perea Pérez, Evelio José

Abstract

The intracellular penetration and activity of linezolid in human polymorphonuclear leukocytes and tissue-cultured cells (McCoy) were evaluated. Linezolid reached intracellular concentrations slightly greater than extracellular ones in both types of cell. The uptake was rapid and not saturable and was affected by environmental temperature and cell viability. Linezolid showed slight intracellular activity against Staphylococcus epidermidis at high extracellular concentrations.

Full text

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2002, p. 4013–4015 Vol. 46, No. 12 0066-4804/02/$04.00⫹0 DOI: 10.1128/AAC.46.12.4013–4015.2002 Copy igh © 2002, Ame ican Socie y o Mic obiology. All Righ s Rese ed. Up ake and In acellula Ac i i y o Linezolid in Human Phagocy es and Nonphagocy ic Cells A ´l a o Pascual,* So ía Balles a, Isabel Ga cía, and E elio J. Pe ea Depa men o Mic obiology, School o Medicine, Uni e si y o Se ille, Se ille, Spain Recei ed 13 No embe 2001/Re u ned o modi ica ion 19 June 2002/Accep ed 12 Augus 2002 The in acellula pene a ion and ac i i y o linezolid in human polymo phonuclea leukocy es and issue- cul u ed cells (McCoy) we e e alua ed. Linezolid eached in acellula concen a ions sligh ly g ea e han ex acellula ones in bo h ypes o cell. The up ake was apid and no sa u able and was a ec ed by en i on- men al empe a u e and cell iabili y. Linezolid showed sligh in acellula ac i i y agains S aphylococcus epide midis a high ex acellula concen a ions. The pene a ion and in acellula ac i i y o an imic obial agen s in phagocy es a e pa icula ly impo an unde condi- ions in which he in ec ing mic oo ganism is able o su i e and mul iply. Se e al in ec ing bac e ia, howe e , a e able o mul iply wi hin nonphagocy ic cells, pa icula ly epi helial cells. Fo hese in ec ions, he use o agen s capable o accu- mula ing and emaining ac i e in such cells could be o po en- ial clinical in e es (9). The high in acellula accumula ion o an an imic obial agen does no always mean good in acellula ac i i y. I is impo an , hen, o e alua e whe he in acellula an imic obial agen s emain ac i e agains bac e ia. Linezolid is an o al oxazolidinone an ibac e ial agen ha ac s by inhib- i ing bac e ial p o ein syn hesis (4, 13–15) and has a wide spec um o ac i i y agains g am-posi i e o ganisms includ- ing me hicillin- esis an S aphylococcus au eus, penicillin- and cephalospo in- esis an pneumococci, and ancomycin- esis- an En e ococcus aecalis and En e ococcus aecium, as well as anae obes such as Clos idium spp., Pep os ep ococcus spp., and P e o ella spp. (1, 5–7). Linezolid is bac e ios a ic agains mos suscep ible o ganisms, bu displays bac e icidal ac i i y agains some s ains o pneumococci, Bac e oides agilis, and Clos idium pe ingens. (2, 3). The e is no in o ma ion abou he in acellula pha macology o hese compounds in human phagocy es and nonphagocy ic cells. The pu pose o his s udy is o e alua e he up ake o linezolid by phagocy es (polymo - phonuclea leukocy es [PMNs]) and nonphagocy ic cells (Mc- Coy). The in acellula ac i i ies o his compound agains S aphylococcus au eus and S aphylococcus epide midis we e also e alua ed. The up ake o adiolabeled linezolid (167 ␮Ci/mg; Pha ma- cia.) by phagocy es and nonphagocy ic cells was de e mined by a eloci y g adien cen i uga ion echnique, as desc ibed by Klempne and S y (8). In hese expe imen s, phagocy es o issue-cul u ed cells we e incuba ed in Hanks’ balanced sal solu ion con aining di e en concen a ions o linezolid (1 o 40 ␮g/ml). A e di e en pe iods o incuba ion a 37°C, he cells we e sepa a ed om he ex acellula solu ion by cen i - uga ion h ough a wa e -impe meable silicone oil ba ie in a mic ocen i uge ube. A 10-␮l aliquo o he ex acellula me- dium and he en i e cell pelle , ob ained by cu ing o he po ion o he mic ocen i uge ube con aining he pelle , we e placed in 3 ml o scin illa ion luid (Ready Mic o; Beckman Ins umen s, Inc., Fulle on, Cali .) and coun ed wi h a liquid scin illa ion coun e (model LS 1801; Beckman). The in acel- lula wa e space was measu ed by using i ia ed wa e and he ex acellula ma ke [ 14 C]polye hylene glycol (1.4 mCi/g; Am- e sham In e na ional, Plc., Buckinghamshi e, Uni ed King- dom). The cells we e incuba ed wi h hese adiolabeled com- pounds o 2 min a 37°C, and hen he cells we e sepa a ed om ex acellula luid by eloci y g adien cen i uga ion and coun ed wi h a liquid scin illa ion coun e . The o al wa e con en o he cell pelle was co ec ed o apped ex acellu- la wa e (i.e., polye hylene glycol space) o ob ain he in a- cellula wa e space. The accumula ion a e o he an imic o- bial agen in PMN (cell-associa ed d ug) o issue-cul u ed cells was calcula ed and exp essed as a cellula /ex acellula concen a ion (C/E) a io (11). The da a a e exp essed as means ⫾s anda d de ia ions. Di e ences be ween g oups we e compa ed by a iance analysis, used o assess s a is ical signi icance a Pⱕ0.05. Figu e 1 shows he kine ics o he up ake o linezolid by human PMNs and McCoy cells. The in acellula pene a ion o linezolid was apid, eaching in acellula concen a ions 1.2 imes highe han he ex acellula concen a ions a e 20 min o incuba ion in bo h kinds o cells. A e 180 min o incuba- ion, he C/E a io alues emained he same o McCoy cells, bu had dec eased by a ound 50% in PMNs. To e alua e whe he linezolid ha had been aken up by human PMNs was igh ly bound o cellula componen s, we e alua ed he kine ics o e lux (Fig. 2). The elu ion o linezolid om human PMN was apid. A e 10 min o incuba ion in an an imic obial- ee medium, 90% o linezolid was eleased. The in acellula pen- e a ion o linezolid in o PMN and McCoy cells was no sa u- able a ex acellula concen a ions anging om 1 o 40 mg/ li e . The C/E a ios in PMNs anged om 0.9 (ex acellula concen a ion, 40 mg/li e ) o 1.3 (ex acellula concen a ion, 20 mg/li e ). A he same ex acellula concen a ion, he C/E a ios anged om 1.1 (ex acellula concen a ion, 40 mg/ li e ) o 1.3 (ex acellula concen a ions, 1, 5, and 20 mg/li e ) in McCoy cells. * Co esponding au ho . Mailing add ess: Depa amen o Mic obi- ology, School o Medicine, Uni e si y o Se ille, A da. Sa´nchez Piz- jua´n s/n, 41009-Se ille, Spain. Phone: 34.5.55008287. Fax: 34.5.4377413. E-mail: [email p o ec ed]. 4013 on July 31, 2017 by USE/BCTA.GEN UNIVERSITARIAh p://aac.asm.o g/Downloaded om Fu he s udies o elucida e he mechanisms o linezolid up ake by PMNs we e pe o med as desc ibed p e iously (10). The in luence o en i onmen al empe a u e (4 e sus 37°C), cell iabili y, and pH (5 o 8) and he e ec s o human se um, pooled se um (5 and 10%), and me abolic inhibi o s (1.5 ⫻ 10 ⫺3 M [each] sodium luo ide and sodium cyanide; Sigma Chemical Co., S . Louis, Mo.) on he up ake o linezolid by PMNs we e e alua ed. The in acellula pene a ion o lin- ezolid in PMNs was also measu ed a e s imula ing he cells wi h 200 nM pho bol my is a e ace a e (PMA; Sigma) and a e phagocy osis o opsonized s aphylococci (in 5% pooled human se um a a 10/1 a io o bac e ia o PMNs) and opso- nized zymosan (0.9 mg/li e ; Sigma) (Table 1). Cell-associa ed linezolid dec eased in iable cells a 4°C (C/E a io, 0.75 ⫾ 0.15; con ol, 1.2 ⫾0.4) and inc eased signi ican ly (P⬍0.05) when dead cells a 37°C we e used (C/E a io, 1.98 ⫾0.15). A possible explana ion o his inc ease migh be ha he o ma- lin used o kill PMNs caused s uc u al changes in he PMNs, which a o ed nonspeci ic binding o he linezolid. This hy- po hesis is cu en ly unde in es iga ion. The up ake o his new oxazolidinone was no a ec ed by ex e nal pH (which anged om 5 o 8). Concen a ions o pooled human se um and di e en me abolic inhibi o s (NaCN and NaF) did no a ec he in acellula pene a ion o his an imic obial agen . Nei he s imula ion o he PMNs by a memb ane ac i a o (PMA) no phagocy osis o opsonized S. au eus and zymosan signi ican ly a ec ed he in acellula pene a ion o linezolid. Mos da a indica ed ha a possible passi e mechanism was in ol ed in he in acellula pene a ion o his agen (7, 12). To e alua e he in acellula ac i i ies o an imic obial agen s, a p e iously desc ibed me hod was used (11). S. au eus ATCC 25923 and S. epide midis ATCC 41134 we e used o killing assays. Suscep ibili y s udies we e de e mined by mi- c odilu ion assay. The MICs o linezolid o hese s ains we e 2 and 1 mg/li e , espec i ely. The da a we e exp essed as pe cen ages o su i ing s aphylococci compa ed wi h he con- ol le els (wi hou an imic obial agen s) a 3 h. In addi ion o de e mining bac e ial su i al, mo phological s udies we e also ou inely pe o med, a ime ze o and a e 3ho incuba ion, o e alua e he disposi ion o bac e ia (cell associa ed o ex- acellula ). All assays we e pe o med in duplica e wi h PMNs om i e di e en dono s. The da a a e exp essed as means ⫾ FIG. 1. Kine ics o linezolid up ake by human PMNs and McCoy cells (n⫽4). Expe imen s we e ca ied ou a ex acellula concen a ions o 10 mg/li e a 37°C. Da a a e exp essed as means ⫾s anda d de ia ions. FIG. 2. E lux o linezolid om human PMNs (n⫽3). A e incu- ba ion wi h 10 mg o linezolid pe li e o 20 min, he cells we e washed and esuspended in an imic obial agen - ee medium. Cell- associa ed linezolid was hen measu ed a di e en imes. TABLE 1. E ec s o a ious condi ions on in acellula pene a ion o linezolid in human PMNs a Condi ion C/E a io b Con ol ( iable cells, 37°C, pH 72) ......................................1.20 ⫾0.40 Viable cells, 4°C......................................................................0.75 ⫾0.17 c Dead cells, 37°C......................................................................1.98 ⫾0.15 c pH 5 ............................................................................................1.30 ⫾0.42 6 ............................................................................................1.13 ⫾0.171 7 ............................................................................................1.18 ⫾0.39 8 ............................................................................................1.20 ⫾0.14 Sodium cyanide.......................................................................1.25 ⫾0.21 Sodium luo ide ......................................................................1.20 ⫾0.14 Human se um 5%.........................................................................................1.37 ⫾0.12 10%.......................................................................................1.47 ⫾0.14 Opsonized PMA .....................................................................1.25 ⫾0.21 Opsonized S. au eus ...............................................................1.35 ⫾0.13 Zymosan................................................................................... 1.3 ⫾0.27 a The condi ions examined include en i onmen al empe a u e, cell iabili y, ex e nal pH, me abolic inhibi o s, se um, memb ane ac i a ion, and phagocy osis o S. au eus and zymosan. b Expe imen s (n⫽4) we e ca ied ou o 20 min a ex acellula concen a- ions o 10 mg/li e . c P⬍0.05 compa ed wi h he con ol. 4014 NOTES ANTIMICROB.AGENTS CHEMOTHER. on July 31, 2017 by USE/BCTA.GEN UNIVERSITARIAh p://aac.asm.o g/Downloaded om s anda d de ia ions. Di e ences be ween g oups we e com- pa ed by a iance analysis, which was used o assess s a is ical signi icance a Pⱕ0.05. A ex acellula concen a ions a ain- able in human se um, linezolid did no a ec he in acellula su i al o s aphylococci. A high ex acellula concen a ions (10 and 20 mg/li e ), linezolid showed sligh in acellula ac- i i y agains S. epide midis, bu no agains S. au eus (Fig. 3). The di e ences in he in acellula ac i i y migh be ela ed o di e ences in he in insic ac i i y o his compound agains bo h s ains. In summa y, linezolid pene a es bo h phagocy es and non- phagocy ic cells, eaching in acellula concen a ions sligh ly g ea e han he ex acellula ones. Linezolid showed sligh in acellula ac i i y agains S. epide midis a high in acellula concen a ions. This wo k was pa ially suppo ed by a g an om Pha macia. REFERENCES 1. B ickne , S. J., D. K. Hu chinson, M. R. Ba bachyn e al. 1996. Syn hesis and an ibac e ial ac i i y o U-100592 and U-100766, wo oxazolidinone an ibac- e ial agen s o he po en ial a men o mul id ug- esis an g am-posi i e bac e ial in ec ions. J. Med. Chem. 36:673–679. 2. Cleme , D., and A. Ma kam. 2000. Linezolid. D ug 59:815–827. 3. Diekema, D. I., and R. N. Jones. 2000. Oxazolidinones: a e iew. D ugs 59:7–16. 4. D esse , L. D., and M. J. Rybak. 1998. The pha macologic and bac e iologic p ope ies o oxazolidinones, a new class o syn he ic an imic obials. Pha - maco he apy 18:456–462. 5. Fo d, C. W., J. C. Hamel, D. M. Wilson, J. K. Moe man, D. S ape , R. J. Yancey, J ., D. K. Hu chinson, M. R. Ba bachyn, and S. J. B ickne . 1996. In i o ac i i ies o U-100592 and U-100766, no el oxazolidinone an imic o- bial agen s, agains expe imen al bac e ial in ec ions. An imic ob. Agen s Chemo he . 40:1508–1513. 6. F ench, G. 2001. Linezolid. In . J. Clin. P ac . 55:59–63. 7. Ga cía, I., A. Pascual, M. C. Guzman, and E. J. Pe ea. 1994. Up ake and in acellula ac i i y o spa loxacin in human polymo phonuclea leukocy es and issue cul u e cells. An imic ob. Agen s Chemo he . 36:1053–1056. 8. Klempne , M. S., and B. S y . 1981. Clindamycin up ake by human neu o- phils. J. In ec . Dis. 144:472–475. 9. Pascual, A. 1995. Up ake and in acellula ac i i y o an imic obial agen s in phagocy ic cells. Re . Med. Mic obiol. 6:228–235. 10. Pascual, A., I. Ga cia, and E. J. Pe ea. 1989. Fluo ome ic measu emen o o loxacin by human polymo phonuclea leukocy es. An imic ob. Agen s Chemo he . 33:653–656. 11. Pascual, A., D. Tsakayama, J. Ko a ik, G. Gekke , and P. K. Pe e son. 1987. Up ake and ac i i y o i apen ine in human pe i oneal mac ophages and polymo phonuclea leukocy es. Eu . J. Clin. Mic obiol. In ec . Dis. 6:152– 157. 12. Pascual, A., I. Ga cía, S. Balles a, and E. J. Pe ea. 1997. Up ake and in acellula ac i i y o o a loxacin in human phagocy es and issue-cul- u ed epi helial cells. An imic ob. Agen s Chemo he . 41:274–277. 13. Shinaba ge , D. L., K. Ma o i, R. W. Mu ay, A. H. Lin, E. P. Melchio , S. M. Swaney, D. S. Dunyak, W. F. Demyan, and J. M. Buysse. 1997. Mechanism o ac ion o oxazolidinones: e ec s o linezolid and epe ezolid on ansla ion eac ions. An imic ob. Agen s Chemo he . 41:2132–2136. 14. Swaney, S. M., H. Aoki, M. C. Ganoza, and D. L. Shinaba ge . 1998. The oxazolidinone inhibi s ini ia ion o p o ein syn hesis in bac e ia. An imic ob. Agen s Chemo he . 42:3251–3255. 15. Zu enko, G. E., B. H. Yagi, R. D. Schaad , J. W. Allison, J. O. Kilbu n, S. E. Glickman, D. K. Hu chinson, M. R. Ba bachyn, and S. J. B ickne . 1996. In i o ac i i ies o U-100592 and U-100766, no el oxazolidinone an ibac e ial agen s. An imic ob. Agen s Chemo he . 40:839–845. FIG. 3. Ac i i y o linezolid agains in acellula S. au eus and S. epide midis in human PMNs (n⫽4). Da a a e exp essed as pe cen - ages o su i ing bac e ia a e 3ho incuba ion compa ed o hose o he con ols wi hou linezolid (means ⫾s anda d de ia ions). *, P⬍ 0.05 compa ed wi h con ol. VOL. 46, 2002 NOTES 4015 on July 31, 2017 by USE/BCTA.GEN UNIVERSITARIAh p://aac.asm.o g/Downloaded om